By Andrew Karpan ( January 14, 2022, 4:11 PM EST) -- A federal court in Delaware has said that a Takeda Pharmaceutical Co. Ltd. unit's patent covering antibodies isn't valid after all, sinking the Japanese multinational's infringement case against the Roche-owned company that makes the blockbuster hemophilia drug Hemlibra....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.